Prima Closes $9.2 Million Seed Plus Financing To Accelerate Growth As Top Player In Plant Therapeutics And Cannabinoid Sciences
May 21, 2021•over 4 years ago
Round Type
seed
Description
The Uplifters' Prima, PBC ("Prima") the award-winning, purpose-driven brand focused on efficacy-driven and science-backed plant therapeutics and cannabinoids, today announced the close of a $9.2 million Seed Plus financing led by leading institutional venture firms Greycroft, H Ventures, Defy, and Lerer Hippeau, with notable participation from Adam Zeplain, Global Founders Capital, Emerald Health, One Gun, and Purple Arch Ventures.